Although some national surveys of drug-abuse treatment have examined cost and financing issues, our study is one of the first to rigorously analyze the costs and financing of methadone treatment at the program level.
Our findings are similar to those found at the national level for treatment cost but deviate significantly from the National Drug and Alcoholism Treatment Unit Survey (NDATUS) findings on funding sources.
In addition to examining financing and total cost, we grouped resources into particular categories and examined variations at the client, program, regimen, and setting levels.
Our specific findings show that public funding sources overwhelmingly support the programs examined.
Mots-clés Pascal : Méthadone, Analgésique narcotique, Traitement substitutif, Chimiothérapie, Traitement, Analyse coût, Economie santé, Financement, Enquête, Etats Unis, Amérique du Nord, Amérique, Homme
Mots-clés Pascal anglais : Narcotic analgesic, Replacement therapy, Chemotherapy, Treatment, Cost analysis, Health economy, Financing, Inquiry, United States, North America, America, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0035125
Code Inist : 002B18H05B. Création : 09/06/1995.